false
0001843714
0001843714
2026-10-06
2026-10-06
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (date of earliest event reported): October 6, 2026
ZAPATA
QUANTUM, INC.
(Exact
name of registrant as specified in charter)
| Delaware |
|
001-41218 |
|
98-1578373 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification
No.) |
6
Liberty Square, #2488
Boston,
MA 02109
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code: (857) 367-9002
(Former
Name and Former Address)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any
of the following provisions:
| |
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ |
Soliciting
material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
7.01 Regulation FD Disclosure.
On
October 6, 2026, Zapata Quantum, Inc. (the “Company”) issued a press release announcing it has joined the IBM Quantum Network
to accelerate mission-driven quantum application development. A copy of the press release is furnished herewith as Exhibit 99.1 of this
Current Report on Form 8-K and is incorporated herein by reference.
The
information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under such section, and shall not be deemed
to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| |
|
|
|
Incorporated
by Reference |
|
Filed
or
Furnished |
| Exhibit
# |
|
Exhibit
Description |
|
Form |
|
Date |
|
Number |
|
Herewith |
| 99.1 |
|
Press Release dated October 6, 2026 |
|
|
|
|
|
|
|
Furnished |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
October 6, 2026
| |
ZAPATA
QUANTUM, INC. |
| |
|
|
| |
By:
|
/s/
Sumit Kapur |
| |
|
Sumit
Kapur, Chief Executive Officer |
Exhibit
99.1
Zapata
Quantum Joins IBM Quantum Network to Accelerate Mission-Driven Quantum Application Development
Effort
builds on prior collaboration to translate high-value use cases into practical applications running on IBM quantum computers
BOSTON,
Massachusetts – October 6, 2026 – Zapata Quantum (OTCQB: ZPTA) (“Zapata”
or the “Company”) today announced it has joined the IBM Quantum Network with
plans to use IBM’s world-class quantum computers with Zapata’s deep expertise
in use-case discovery and application development. The Company’s effort aims to help
close the quantum application gap by translating advances in quantum computing into mission-critical
applications and real-world impact.
“The
rapid progress IBM is making on the path to fault-tolerant quantum computing brings the quantum application gap into sharper focus,”
said Sumit Kapur, CEO of Zapata Quantum. “These advances must be matched by progress in identifying, evaluating and developing
the applications that will deliver real-world value. We are excited for Zapata’s Quantum Application Intelligence™ to translate
organizations’ highest-mission priorities into practical quantum applications.”
“IBM’s
roadmap to fault-tolerant quantum computing is one of the most credible in the industry, and superconducting qubits remain one of the
most capable paths to advantage because their hardware is fast,” said Jonny Olson, VP Strategy and Co-Founder of Zapata
Quantum. “Joining the IBM Quantum Network lets us better identify valuable opportunities for organizations that need the fastest
systems, and then prepare those organizations for the precise moment that quantum gives them real ROI.”
Joining
the IBM Quantum Network builds on a history of joint IBM and Zapata research done on early quantum devices. Zapata used IBM quantum computers
in a landmark study published in Nature Biotechnology that produced experimentally validated candidates targeting KRAS and was
selected as one of the journal’s Top 10 Articles of 2025.¹ Scientists from the two companies also co-authored research published
in npj Quantum Information, which advanced the understanding of variational quantum factoring on a superconducting processor.2
Being
part of the IBM Quantum Network also reflects Zapata’s broader strategy of working with technology leaders across the quantum and
AI ecosystems. Insights from being part of the IBM Quantum Network will inform Quantum Pilot™, Zapata’s hardware-agnostic
platform that helps enterprises identify, prioritize, and develop quantum applications as hardware matures.
To
learn more about Zapata’s work in quantum application development, please visit the Company’s website.
About
Zapata Quantum
Zapata
Quantum is a leading hardware-agnostic, pure-play quantum software company focused on accelerating quantum application development. With
a portfolio of more than 60 granted and pending patents developed over seven years, Zapata supports applications across cryptography,
pharmaceuticals, finance, materials discovery, defense, and more. The Company is the only organization to have participated across all
technical areas of DARPA’s Quantum Benchmarking program and has worked with Fortune 500 enterprises and government agencies to
translate quantum advances into real-world impact. The Company’s study demonstrating the potential of quantum-enabled drug discovery
was recognized as one of Nature Biotechnology’s Top 10 Papers of 2025. Learn more at zapataquantum.com.
Forward-Looking
Statements
This
press release contains forward-looking statements, including statements regarding the use of IBM’s quantum computers and the potential
future applications and benefits of quantum applications and prospective opportunities and value that could be generated therefrom. Forward-looking
statements may be prefaced by words such as “anticipate,” “expect,” “plan,” “could,”
“may,” “will,” “should,” “would,” “intend,” “seem,” “potential,”
“appear,” “continue,” “future,” “believe,” “estimate,” “forecast,”
“project,” and similar words and expressions as they relate to us, are intended to identify forward-looking statements. Forward-looking
statements are neither historical facts nor assurances of future performance, and are based on our current beliefs, expectations and
assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, the economy and other future
conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in
circumstances that are difficult to predict, many of which are outside of our control. We caution you, therefore, against relying on
any of these forward-looking statements. Our actual results may differ materially from those contemplated by the forward-looking statements
for a variety of reasons, including, without limitation, our ability to identify, develop and commercialize quantum computing technologies
and practical applications for such technologies, our ability to secure and maintain contracts with customers and collaborators, the
state of the U.S. economy including issues caused by affordability, the risk of future inflation and uncertainty surrounding interest
rates and the possibility of a recession, uncertainty surrounding and impacts arising from tariffs and developments relating thereto,
our ability to attract and retain key personnel, our ability to obtain, maintain and protect intellectual property rights, the risk that
software and technology infrastructure on which we depend fails to perform as designed or intended, the possibility that competitors
may develop or access technology with similar or superior capabilities to our technology offerings, the possibility of adverse regulatory
developments that could adversely impact us or our collaborators or the technologies on which we depend, and the risk factors contained
in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (the “SEC”)
on March 31, 2026, and our Prospectus filed with the SEC on August 11, 2026. Any forward-looking statement made by us in this press release
speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time
to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement,
whether as a result of new information, future developments or otherwise, except as may be required by law.
Media
Contact
Taylor
White
taylor@hkamarcom.com
Investor
Relations Contact
Richard
Land
investors@zapataquantum.com
| 1. | Ghazi
Vakili, M., Gorgulla, C., Snider, J. et al. Quantum-computing-enhanced algorithm unveils
potential KRAS inhibitors. Nat Biotechnol 43, 1954–1959 (2025). https://doi.org/10.1038/s41587-024-02526-3 |
| 2. | Karamlou,
A.H., Simon, W.A., Katabarwa, A. et al. Analyzing the performance of variational quantum
factoring on a superconducting quantum processor. npj Quantum Inf 7, 156 (2021). https://doi.org/10.1038/s41534-021-00478-z |
